Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
European Urology
|
May 22, 2022
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Yohann Loriot, Matthieu Texier, Stéphane Culine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2025
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
Michel Ducreux, Romain Desgrippes, Yves Rinaldi, et al.
British Journal of Cancer
|
December 14, 2023
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, et al.
ACS Nano
|
June 24, 2024
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer
Cyrus Chargari, Pauline Maury, Matthieu Texier, et al.
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Cancer Research
|
November 13, 2016
A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents
Antoine Azan, Peter J Caspers, Tom C Bakker Schut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Roberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Lancet (London, England)
|
February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
Eric Baudin, Bernard Goichot, Alfredo Berruti, et al.
The Lancet. Oncology
|
July 28, 2020
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goéré, Olivier Glehen, François Quenet, et al.
Signal Transduction and Targeted Therapy
|
March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
European Urology
|
May 22, 2022
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Yohann Loriot, Matthieu Texier, Stéphane Culine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2025
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
Michel Ducreux, Romain Desgrippes, Yves Rinaldi, et al.
British Journal of Cancer
|
December 14, 2023
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, et al.
ACS Nano
|
June 24, 2024
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer
Cyrus Chargari, Pauline Maury, Matthieu Texier, et al.
Molecular Cancer
|
March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Cancer Research
|
November 13, 2016
A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents
Antoine Azan, Peter J Caspers, Tom C Bakker Schut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Roberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Lancet (London, England)
|
February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
Eric Baudin, Bernard Goichot, Alfredo Berruti, et al.
The Lancet. Oncology
|
July 28, 2020
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goéré, Olivier Glehen, François Quenet, et al.
Signal Transduction and Targeted Therapy
|
March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Page
of 3